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A new concept of within-individual epidemiology termed “myEpi” is introduced. It is
argued that traditional epidemiological methods, which are usually applied to populations
of humans, can be applicable to a single individual and thus used for self-monitoring and
forecasting of “epidemic” outbreaks within an individual.Traditional epidemiology requires
that results be generalizable to a predefined population. The key component of myEpi is
that a single individual may be viewed as an entire population of events and thus, the analy-
sis should be generalizable to this population. Applications of myEpi are aimed for, but not
limited to, the analysis of data collected by individuals with the help of wearable sensors
and digital diaries. These data can include physiological measures and records of healthy
and risky behaviors (e.g., exercise, sleep, smoking, food consumption, alcohol, and drug
use). Although many examples of within-individual epidemiology exist, there is a pressing
need for systematic guidance to the analysis and interpretation of intensive individual-level
data. myEpi serves this need by adapting statistical methods (e.g., regressions, hierarchical
models, survival analysis, agent-based models) to individual-level data.
Keywords:mobile health, epidemiology, statistics, data science,myEpi,wearable devices, evidence-based practice,
self-care
EPIDEMIOLOGY AND myEpi
Epidemiology, literally “the study of what is upon the people,” is
defined as the science of the incidence, distribution, and control
of disease conditions in a population (1). Epidemiology provides
public health and policy makers with evidence such as risk fac-
tors for disease and targets for preventive medicine. Epidemiology
does not focus on a specific individual; treating disease conditions
of an individual is traditionally left to the clinical field. At the
same time, more individuals are showing active interest in their
own health; and more physicians are interested in incorporating
the wealth of existing information into their practices. When the
focus is on the health and behavior of a specific individual, use
of epidemiological methods can lead to confusion. On one hand,
evidence-based principles state that practical decisions should be
based on research studies. In fact, knowing that smoking leads to
a plethora of health conditions including cancer is a good motiva-
tion for an individual to quit smoking, and for a never-smoker not
to initiate. On the other hand, overreliance on population-level
evidence can lead to a well-known ecological fallacy when health
risks (or lack thereof) are erroneously projected onto an individ-
ual. For example, lawsuits have been initiated when a physician
relies on evidence and assumes low risk and a patient develops a
health condition (2).
In this article, I introduce the concept of individual epidemi-
ology (myEpi), which aims to provide individual-level inference.
By definition, myEpi considers an individual as a population of
person-level events and behaviors (Figure 1) and thus inferences
about an individual can be obtained from within-person data.
MyEpi does not ignore evidence collected from others in the
population, in fact it embraces these data in the same way epidemi-
ological studies embrace environmental factors. In this sense, the
polluted environment of a faulty chemical plant could contribute
to the increased risk of disease in a neighboring town, similar to
the way disease status of close relatives (genetics) or social net-
works (behavioral influence) contributes to an increase in disease
risk for an individual.
AVAILABLE DATA
Over the last decade, a revolution in data collection within an
individual (e.g., electronic diaries, ecological momentary assess-
ments, and multiple physiological sensors) has allowed for the
collection of large amounts of “intensive” data (3). Although tra-
ditional methods such as Timeline Followback (4) are still being
used for research purposes, web, and mobile applications allow
one to record and analyze data in real time. Although the design,
quality, and ownership of the data remain subjects of evolving
research and policies, one thing is evident: data collected by an
individual and for the use by that individual can have a strong
impact on that person’s health and behavior.
Statistical requirements for myEpi data follow the same statisti-
cal power rules as a traditional epidemiological study; a longitudi-
nal study with sufficient observations could potentially be used for
helping a specific patient. In decision sciences, the requirements
for the amount of data can be relaxed in exceptional cases when
individual data carry critical information. For example, in a hypo-
thetical situation three antibiotics (A, B, and C) are available to
treat a patient. If a patient developed severe allergic reaction in the
past to drugs A and B on two separate occasions, then the only
available option is C. This decision is likely to be made regardless
of whether population-level clinical trials show that drug B is most
efficacious. In this example, the presence of only two observations
is sufficient to rule out two of three antibiotics.
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FIGURE 1 | An illustration of inferring to an individual form the
population-level and individual-level data. The green “myEpi” oval
denotes within-person data which could be also combined with information
about blood relatives, social networks, as well as the entire population and
the environment. The purpose of the analysis, however, is the
individual-level inference.
This example also illustrates that data for medical decision pur-
poses should be of high quality. In reality, without the availability
of electronic health records, healthcare providers often rely on
patients’ recollections of past events, often with a long time lag
and thus reduced reliability. Additionally, medical records often
do not include events that happen outside health care. In addition
to and sometimes instead of formal healthcare individuals some-
times rely on personal opinion and experience and the advice of
family, influential social network members, advertisement, etc. (5,
6). Recordings of self-treatment and outcomes become more avail-
able and should be used to provide insights into individuals’ health
and behavior.
AVAILABLE ANALYSIS METHODS
These within-person data are different from data traditionally
collected in epidemiological studies, but myEpi can adapt most
methodology from traditional epidemiological methods. Below
are a few examples. When collecting multiple observations per
subject, epidemiologists have studied between- and within-subject
variation for decades and used regression-based tools like Hierar-
chical Linear Models. In epidemiological studies within-subject
variation represents the average over many individuals rather than
the variation within a single individual. In myEpi, the focus is
on variability within an individual (3, 7–9). Bayesian methods
open an opportunity to combine evidence from population-
level research with observed data from a specific individual,
thus borrowing strength from the group where actual data are
lacking (10).
Infectious diseases such as measles and influenza have been
extensively studied using epidemic surveillance and mathematical
models (11). These models are based on daily or regular incidence
FIGURE 2 | A “moving windows”method to identify patterns of
alcohol use trajectories. Distributional properties of sliding windows Wt
and Wt+s−1 are compared to each other. The point when the distributions
become significantly different signifies the change in patterns. We illustrate
the point at which the pattern switched from type 5 to 7 as the number of
drinks increases. The figure is reproduced with permission from Ref. (8).
reports and if model parameters are well calibrated the model can
predict the course of an epidemic (11–13) and evaluate strategies
to contain it (12, 13). The same methods, such as distinguish-
ing an emerging epidemic from occasional outbreaks, can be used
when considering individual data. The application again requires
a change of mindset. Similar to considering regular (e.g., weekly or
monthly) disease incidence reports one can consider regular (e.g.,
daily or weekly) reports of specific events. These events could be
categorical (e.g., exercised or not), count (e.g., drank five beers), or
continuous (e.g., consumed 3680 calories). In substance use stud-
ies, a number of tools are available to track alcohol and tobacco
consumption; drawing an analogy with an infectious epidemic,
the tools can detect the start of increased use (8) (Figure 2), pre-
dict most likely moment for relapse (14), predict future use (15),
and identify strategies to influence the recovery process (16, 17).
Survival analysis has been broadly used to estimate exposure
risks in the population and survival curves can show, for exam-
ple, survival from HIV among men who have sex with men in a
long-term cohort study (18). Although the study emphasized that
condoms and antiretroviral treatment (ART) work as preventive
factors, it tells little about individuals’ chances to seroconvert. At
the same time, knowledge of individual sexual and drug-using
behavior in discordant couples allows one to estimate the timing
of HIV seroconversion (7). Changes in individual behavior (e.g.,
compliance with ART) alter the HIV-negative survival of a partner
(Figure 3).
For complex problems involving health systems and adaptive
behavior computational methods become very popular (9, 19).
Agent-based models (ABMs) have recently become powerful tools
to estimate the effects of interventions on community and pop-
ulation health (20, 21). At the same time, ABMs allow one to
track an individual and examine what could potentially happen
to this specific individual over the course of time under different
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FIGURE 3 | Survival curves for staying HIV negative for a female with a male HIV-positive partner in a latent HIV stage, assuming two unprotected
vaginal intercourses per week. Model details and parameters are described in detail in Ref. (7).
scenarios (22). Modeling an individual in the context of social
network and a series of individual events is in its infancy, espe-
cially when considering health outcomes. However, this area has
been progressively developed in the context of military actions and
response to terrorism (23).
INTERPRETATION OF DATA SUMMARIES AND BEHAVIOR
CHANGE
Besides professionally designed and analyzed studies, individuals
collect large amounts of data for their personal interpretation and
decision making. Machine learning tools that are being developed
as part of the “Big Data” research agenda can provide people with
real-time interpretations of their data. Incorporation of these tools
in the backbone of mobile apps is likely to play a crucial role in
the future. At the same time, understanding probability, associa-
tions, causality, and uncertainty to the users of thousands of web
and mobile applications becomes critical because these interpre-
tations affect health and behavior decisions. Just as a public health
policymaker needs to understand and interpret epidemiology, an
individual needs to understand and interpret individual data for
personal decisions.
An individual can also compare him- or her-self to other indi-
viduals, trends, and percentiles in the available sample. In this
sense, such analysis is similar to how cross-cultural and cross-
country comparisons are made in epidemiology. However, myEpi
emphasizes considering these trends and percentiles only as a
context for an individual trend. For example, if an individual is
monitoring his or her blood pressure he or she might also like to
compare it with national statistics, daily and annual trends, etc.
However, the most important comparison is with norms for self.
Some people can naturally have lower blood pressure and a sud-
den jump in pressure can be worrisome even if it remains below
the national norm. Analogously, an infant can develop perfectly
well according to her own growth curve, which might be in a low
or high national percentile.
CONTROL OF PERSONAL HEALTH
Control of national epidemics has been a prerogative of the gov-
ernment’s public health system. Control of individual health,
however, has been more ambiguous, with a large role placed on
physicians and health care providers in general but mostly for the
treatment of disease. Prevention has traditionally been a part of
individuals’ everyday life. At the same time, public health officials
and physicians have been trained for years to recognize patterns
within populations, groups of patients, and a single individual,
while the majority of individuals are not trained to monitor them-
selves in a systematic way. This lack of statistical training often
results in superstitions and ungrounded beliefs. Currently, the
availability of data collecting and monitoring tools could poten-
tially lead to more ungrounded beliefs and erroneous conclusions
if rigorous and reliable help is not provided to individuals for
analysis of their own data.
LINK BETWEEN EPIDEMIOLOGY AND myEpi
One of the disputed issues in the use of individual data is their
generalizability to a larger population. Under the myEpi con-
cept, models and methods should not necessarily be generaliz-
able to the population (it would be an additional merit if they
were) but should show validity within an individual. This distinc-
tion becomes increasingly important in the process of funding
and publication reviews and more discussion of good analysis
practices are needed. Although myEpi is focused on the indi-
vidual, it has important potential in the improvement of pub-
lic health by acting on one person at a time. The application
areas could be different (e.g., monitoring sleep, blood pressure,
food and exercise, tracking cigarettes smoked) and the results
will vary drastically by the application, tool, and individual.
However, my hypothesis is that those individuals who use myEpi
(i.e., monitor their health using intelligent tools and rigorous
methods) would improve their well-being more than those who
do not.
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